• BX Home
  • Abbott Laboratories: News [Page 22]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

ABBOTT LABORATORIES

Abbott Laboratories is a diversified pharmaceuticals healthcare company headquartered in Abbot Part, Illinois. It operates in four segments: pharmaceutical products; diagnostic products; nutritional products; and vascular products. In 1985, Abbott develop dthe first HIV screen test. The company’s drug portfolio includes Humira, Synthroid, and Dupakote; and its most popular nutritional product is Ensure.

Abbott Laboratories is part of Business Exchange, suggested by Maki Yamasaki. This topic contains 921 news and 191 blog items. Read updated news, blogs, and resources about Abbott Laboratories. Find user-submitted articles and reactions on Abbott Laboratories from like-minded professionals.

News

Please add new articles to this topic

UPDATE 1-U.S. panel splits on Abbott diet drug banmore

ADELPHI, Md., Sept 15 (Reuters) - A U.S. advisory panel was divided over whether to recommend banning Abbott...

How Expensive Is Abbott Laboratories Stock Right Now?more

value based on the following clues: Let's see what those numbers can tell us about how cheap Abbott Laboratories (NYSE:...

The One Thing You Must Know About Abbott Laboratoriesmore

we've found several crucial characteristics of quality management. Today, we'll size up the recent performance of...

Abbott abandons plans to sell vaccines businessmore

WASHINGTON -- Drug and medical device firm Abbott Laboratories said Friday it has abandoned plans to sell its vaccines...

Abbott ends auction of vaccines businessmore

Reprints tool at the top of any article or visit: www.reutersreprints.com. NEW YORK (Reuters) - Drugmaker Abbott...

Abbott Abandons Sale of Unitmore

Abbott Laboratories pulled the plug on the sale of its European flu-vaccine business when initial bids came in below...

FDA urged to pull Abbott diet drugmore

and should not be taken for more than two years. After the drug's approval, North Chicago-based manufacturer Abbott...

Abbott-funded study backs data that its Merida drug has heart risksmore

Related Content (Reuters) ? A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss...

Diet drug Meridia study renews calls for U.S. banmore

WASHINGTON - A study funded by Abbott Laboratories offered more detailed evidence that its weight-loss drug Meridia...

Skyepharma slides as US group ends asthma drug dealmore

Skyepharma have fallen around 5% after another setback for its asthma treatment flutiform. The company has announced...

HUMOUR: Study Finds Lab Rats Fed Organic Diet, Pretentious & Annoy...more

A university research group recently found that even mice have the ability to snub their tiny noses. The research shows...

Study: Employees lax on preventive caremore

The study includes responses from the group's membership of some of the nation's largest employers, including Abbott...

Does Bill Miller Think Abbott Laboratories Is Attractive?more

of repurchasing shares A P/E less than 25 Here's what I found: 5-Year Dividend Growth Share Shrink Abbott Laboratories...

MNCs paying premium for assets of listed cosmore

a feeling shared by all. Piramal Healthcare chairman Ajay Piramal defended the decision to sell formulation business to...

Drug market grows 20% in H1; foreign firms tighten holdmore

market grew 19.6% in the first six months of the year, headed by new leader American company Abbott Laboratories, as...

Tribune bankruptcy examiner chides a board dominated by Chicago busine...more

William Osborn, the now-retired CEO of Northern Trust Co., who chaired the special committee that evaluated the deal;...

CORRECT: FDA Panel To Review Abbott, Arena Drugs Over 2 Daysmore

follows.) NEW YORK (Dow Jones)--A Food and Drug Administration advisory committee will review the safety risk of Abbott...

Abbott Labs CEO Says He Walks A Tightropemore

Every year for 38 years, Abbott Laboratories has paid shareholders a dividend greater than that paid the year before.

DEALTALK - Sanofi's best bet still may be smaller dealsmore

companies that pursue only large acquisitions, the Bain study found. Over the past two decades, companies such as...

7 Funds Laying Odds on Health Caremore

corners of the industry, including medical devices (ICU Medical (ICUI)), biotech (Biogen Idec (BIIB)), drug development...

Abbott's 2nd-quarter earnings flatmore

Abbott Laboratories reported flat second-quarter earnings, as charges related to legal and research expenses and costs...

Abbott Posts Flat Earningsmore

Abbott Laboratories' second-quarter earnings were flat as acquisition costs offset double-digit sales growth.

Abbott Beats The Street And Gets A Treatmore

Developer, manufacturer, and distributer of health care products, Abbott Laboratories, released its quarterly earnings...

FDA Sends Warning Letter To Abbott Diabetes Unitmore

WASHINGTON -(Dow Jones)- The Food and Drug Administration warned Abbott Laboratories' (ABT) diabetes unit about...

CCC | Are You Over-Serving Your Most Valuable Customers?more

Segmentation, tiered service—call it what you may, many companies are taking a second look at serving customers based...

Top Sources: Abbott Laboratories

  • BusinessWeek
  • MarketWatch
  • Reuters
  • Chicago Tribune
  • thedeal.com
  • chicagobusiness.com
  • CNN Money
  • TheStreet.com
  • CNBC
  • innovationexcellence.com

Most Active Users in this Topic

see all contributors in Abbott Laboratories

Featured White Papers

Post a Job

Jobs in this Topic

Director, Laboratory Operations Abbott Laboratories | Irvine, CA
Posted: Jan 30
Sr. Director Regulatory Affairs Abbott Laboratories | Carlsbad, CA
Posted: May 20
WAREHOUSE SUPERVISOR Abbott Laboratories | Milpitas, CA
Posted: May 2
Master Data Coordinator Abbott Laboratories | Santa Ana, CA
Posted: May 23
Sr Product Manager, US Endovascular Abbott Laboratories | Santa Clara, CA
Posted: May 13

Report comment contains invalid characters. ()
cancel
Search Cancel